Literature DB >> 26634312

Vaccines and Kawasaki disease.

Susanna Esposito1, Sonia Bianchini1, Rosa Maria Dellepiane2, Nicola Principi1.   

Abstract

The distinctive immune system characteristics of children with Kawasaki disease (KD) could suggest that they respond in a particular way to all antigenic stimulations, including those due to vaccines. Moreover, treatment of KD is mainly based on immunomodulatory therapy. These factors suggest that vaccines and KD may interact in several ways. These interactions could be of clinical relevance because KD is a disease of younger children who receive most of the vaccines recommended for infectious disease prevention. This paper shows that available evidence does not support an association between KD development and vaccine administration. Moreover, it highlights that administration of routine vaccines is mandatory even in children with KD and all efforts must be made to ensure the highest degree of protection against vaccine-preventable diseases for these patients. However, studies are needed to clarify currently unsolved issues, especially issues related to immunologic interference induced by intravenous immunoglobulin and biological drugs.

Entities:  

Keywords:  Aspirin; Kawasaki disease; biological drugs; immunosuppressive therapy; intravenous immunoglobulin

Mesh:

Substances:

Year:  2015        PMID: 26634312     DOI: 10.1586/14760584.2016.1128329

Source DB:  PubMed          Journal:  Expert Rev Vaccines        ISSN: 1476-0584            Impact factor:   5.217


  6 in total

1.  A Comprehensive Update on Kawasaki Disease Vasculitis and Myocarditis.

Authors:  Priya R Soni; Magali Noval Rivas; Moshe Arditi
Journal:  Curr Rheumatol Rep       Date:  2020-02-05       Impact factor: 4.686

Review 2.  Kawasaki disease: guidelines of the Italian Society of Pediatrics, part I - definition, epidemiology, etiopathogenesis, clinical expression and management of the acute phase.

Authors:  Alessandra Marchesi; Isabella Tarissi de Jacobis; Donato Rigante; Alessandro Rimini; Walter Malorni; Giovanni Corsello; Grazia Bossi; Sabrina Buonuomo; Fabio Cardinale; Elisabetta Cortis; Fabrizio De Benedetti; Andrea De Zorzi; Marzia Duse; Domenico Del Principe; Rosa Maria Dellepiane; Livio D'Isanto; Maya El Hachem; Susanna Esposito; Fernanda Falcini; Ugo Giordano; Maria Cristina Maggio; Savina Mannarino; Gianluigi Marseglia; Silvana Martino; Giulia Marucci; Rossella Massaro; Christian Pescosolido; Donatella Pietraforte; Maria Cristina Pietrogrande; Patrizia Salice; Aurelio Secinaro; Elisabetta Straface; Alberto Villani
Journal:  Ital J Pediatr       Date:  2018-08-30       Impact factor: 2.638

3.  Kawasaki Disease and the Use of the Rotavirus Vaccine in Children: A Systematic Review and Meta-Analysis.

Authors:  Natália Gibim Mellone; Marcus Tolentino Silva; Mariana Del Grossi Paglia; Luciane Cruz Lopes; Sílvio Barberato-Filho; Fernando de Sá Del Fiol; Cristiane de Cássia Bergamaschi
Journal:  Front Pharmacol       Date:  2019-09-24       Impact factor: 5.810

Review 4.  Revised recommendations of the Italian Society of Pediatrics about the general management of Kawasaki disease.

Authors:  Alessandra Marchesi; Donato Rigante; Rolando Cimaz; Angelo Ravelli; Isabella Tarissi de Jacobis; Alessandro Rimini; Fabio Cardinale; Marco Cattalini; Andrea De Zorzi; Rosa Maria Dellepiane; Patrizia Salice; Aurelio Secinaro; Andrea Taddio; Paolo Palma; Maya El Hachem; Elisabetta Cortis; Maria Cristina Maggio; Giovanni Corsello; Alberto Villani
Journal:  Ital J Pediatr       Date:  2021-01-25       Impact factor: 2.638

Review 5.  Hygiene Hypothesis as the Etiology of Kawasaki Disease: Dysregulation of Early B Cell Development.

Authors:  Jong-Keuk Lee
Journal:  Int J Mol Sci       Date:  2021-11-15       Impact factor: 5.923

6.  Demonstration of background rates of three conditions of interest for vaccine safety surveillance.

Authors:  Anne E Wormsbecker; Caitlin Johnson; Laura Bourns; Tara Harris; Natasha S Crowcroft; Shelley L Deeks
Journal:  PLoS One       Date:  2019-01-15       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.